MiMedx Says It Will Beat High End of Q3 Revenue Guidance
It appears that MiMedx Group will need to make more room in its coffers quite soon. The company announced that it will exceed the top end of its revenue guidance range for its Q3. It now expects to post a figure of $16.1 million, or roughly $100,000 higher than the maximum anticipated $16.0 million.
That $16.1 million would represent a gain of more than double the Q3 2012 figure.
In the press release on the news, MiMedx pointed out that this will be the eighth quarter in a row that it has met or exceeded its revenue guidance range.
Meanwhile, the firm tightened its top-line guidance for the entirety of fiscal 2013. It boosted the low end of that range, and now expects to take in $57 million to $60 million for the year. Previously, the former number was $54 million.
MiMedx is scheduled to unveil its Q3 results on October 30.
The article MiMedx Says It Will Beat High End of Q3 Revenue Guidance originally appeared on Fool.com.
Fool contributor Eric Volkman has no position in MiMedx Group. Nor does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
